C.I. Medical Co.,Ltd. (TYO:3540)
898.00
-5.00 (-0.55%)
May 23, 2025, 3:30 PM JST
C.I. Medical Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 3,543 | 4,124 | 1,698 | 1,731 | 3,649 | 5,680 | Upgrade
|
Short-Term Investments | 60 | 111 | 106 | 95 | 32 | - | Upgrade
|
Cash & Short-Term Investments | 3,603 | 4,235 | 1,804 | 1,826 | 3,681 | 5,680 | Upgrade
|
Cash Growth | 175.25% | 134.76% | -1.21% | -50.39% | -35.19% | 131.93% | Upgrade
|
Accounts Receivable | 4,907 | 5,346 | 3,263 | 3,045 | 2,555 | 2,610 | Upgrade
|
Other Receivables | 3,450 | 3,649 | 3,405 | 1,333 | 1,242 | 1,106 | Upgrade
|
Receivables | 8,357 | 8,995 | 6,668 | 4,378 | 3,797 | 3,716 | Upgrade
|
Inventory | 15,066 | 15,634 | 8,587 | 7,226 | 6,169 | 5,536 | Upgrade
|
Other Current Assets | 1,519 | 1,476 | 789 | 644 | 802 | 930 | Upgrade
|
Total Current Assets | 28,545 | 30,340 | 17,848 | 14,074 | 14,449 | 15,862 | Upgrade
|
Property, Plant & Equipment | 12,852 | 24,253 | 20,470 | 13,831 | 4,153 | 1,546 | Upgrade
|
Long-Term Investments | 6,775 | 6,659 | 1,115 | 295 | 324 | 442 | Upgrade
|
Goodwill | 454 | 473 | 546 | 619 | - | - | Upgrade
|
Other Intangible Assets | 747 | 1,121 | 1,250 | 1,088 | 743 | 686 | Upgrade
|
Long-Term Deferred Tax Assets | 400 | 319 | 276 | 278 | 245 | 360 | Upgrade
|
Other Long-Term Assets | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
Total Assets | 49,774 | 63,166 | 41,506 | 30,186 | 19,915 | 18,897 | Upgrade
|
Accounts Payable | 7,272 | 8,532 | 1,726 | 1,730 | 1,481 | 1,602 | Upgrade
|
Accrued Expenses | 195 | 45 | 31 | 24 | 8 | 7 | Upgrade
|
Short-Term Debt | 3,200 | 19,200 | 17,100 | 7,000 | - | - | Upgrade
|
Current Portion of Long-Term Debt | 826 | 160 | 29 | 27 | - | - | Upgrade
|
Current Income Taxes Payable | 3,899 | 3,835 | 1,687 | 2,113 | 1,679 | 2,396 | Upgrade
|
Other Current Liabilities | 982 | 1,219 | 296 | 522 | 351 | 729 | Upgrade
|
Total Current Liabilities | 16,374 | 32,991 | 20,869 | 11,416 | 3,519 | 4,734 | Upgrade
|
Long-Term Debt | 4,389 | 1,849 | 64 | 65 | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 174 | 299 | - | - | - | - | Upgrade
|
Other Long-Term Liabilities | 637 | 631 | 435 | 426 | 418 | 408 | Upgrade
|
Total Liabilities | 21,574 | 35,770 | 21,368 | 11,907 | 3,937 | 5,142 | Upgrade
|
Common Stock | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
Retained Earnings | 26,835 | 26,094 | 20,079 | 18,249 | 16,009 | 13,773 | Upgrade
|
Comprehensive Income & Other | -28 | -9 | -31 | -43 | -41 | -28 | Upgrade
|
Total Common Equity | 26,818 | 26,095 | 20,058 | 18,216 | 15,978 | 13,755 | Upgrade
|
Minority Interest | 1,382 | 1,301 | 80 | 63 | - | - | Upgrade
|
Shareholders' Equity | 28,200 | 27,396 | 20,138 | 18,279 | 15,978 | 13,755 | Upgrade
|
Total Liabilities & Equity | 49,774 | 63,166 | 41,506 | 30,186 | 19,915 | 18,897 | Upgrade
|
Total Debt | 8,415 | 21,209 | 17,193 | 7,092 | - | - | Upgrade
|
Net Cash (Debt) | -4,812 | -16,974 | -15,389 | -5,266 | 3,681 | 5,680 | Upgrade
|
Net Cash Growth | - | - | - | - | -35.19% | 131.93% | Upgrade
|
Net Cash Per Share | -96.24 | -339.49 | -307.81 | -105.33 | 73.62 | 113.60 | Upgrade
|
Filing Date Shares Outstanding | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
Total Common Shares Outstanding | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
Working Capital | 12,171 | -2,651 | -3,021 | 2,658 | 10,930 | 11,128 | Upgrade
|
Book Value Per Share | 536.37 | 521.91 | 401.17 | 364.33 | 319.56 | 275.10 | Upgrade
|
Tangible Book Value | 25,617 | 24,501 | 18,262 | 16,509 | 15,235 | 13,069 | Upgrade
|
Tangible Book Value Per Share | 512.35 | 490.03 | 365.25 | 330.18 | 304.70 | 261.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.